Drug Shortage Report for TEVA-TOBRAMYCIN
| Report ID | 227495 |
| Drug Identification Number | 02389622 |
| Brand name | TEVA-TOBRAMYCIN |
| Common or Proper name | TOBRAMYCIN 300mg/5ml |
| Company Name | TEVA CANADA LIMITED |
| Market Status | MARKETED |
| Active Ingredient(s) | TOBRAMYCIN |
| Strength(s) | 60MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INHALATION INHALATION |
| Packaging size | 56 |
| Anatomical Therapeutical Chemical (ATC) code | J01GB |
| Anatomical Therapeutical Chemical (ATC) description | AMINOGLYCOSIDE ANTIBACTERIALS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2024-05-08 |
| Estimated end date | 2026-02-20 |
| Actual end date | 2026-02-25 |
| Shortage status | Resolved |
| Updated date | 2026-02-26 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v46 | 2026-02-26 | French | Compare |
| v45 | 2026-02-26 | English | Compare |
| v44 | 2026-02-05 | French | Compare |
| v43 | 2026-02-05 | English | Compare |
| v42 | 2026-01-15 | French | Compare |
| v41 | 2026-01-15 | English | Compare |
| v40 | 2025-12-11 | French | Compare |
| v39 | 2025-12-11 | English | Compare |
| v38 | 2025-11-27 | French | Compare |
| v37 | 2025-11-27 | English | Compare |
| v36 | 2025-10-02 | French | Compare |
| v35 | 2025-10-02 | English | Compare |
| v34 | 2025-09-11 | French | Compare |
| v33 | 2025-09-11 | English | Compare |
| v32 | 2025-08-21 | French | Compare |
| v31 | 2025-08-21 | English | Compare |
| v30 | 2025-08-08 | French | Compare |
| v29 | 2025-08-08 | English | Compare |
| v28 | 2025-06-13 | French | Compare |
| v27 | 2025-06-13 | English | Compare |